Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN vs BELINOSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELANTAMAB MAFODOTIN vs BELINOSTAT: Safety Overview

Metric BELANTAMAB MAFODOTIN BELINOSTAT
Total FAERS Reports 2,293 305
Deaths Reported 843 103
Death Rate 36.8% 33.8%
Hospitalizations 599 123
Average Patient Age 67.3 yrs 62.0 yrs
% Female Patients 39.2% 40.4%
FDA Approval Date N/A Jul 3, 2014
Manufacturer GlaxoSmithKline LLC Acrotech Biopharma Inc
Route INTRAVENOUS INTRAVENOUS
Marketing Status N/A Prescription